AR and neoplasm: The lack of association between AR CN gene and PSA response rate could have an explanation in possible changes of tumor biology during enzalutamide that were not present before treatment (e.g. neuroendocrine differentiation), even if a bias due to the small sample size needs to be considered [15, 16].